Choroideremia Treatment Market Players:
- Novartis AG
- Spark Therapeutics
- Bluebird Bio Inc.
- Biogen Inc.
- Copernicus Therapeutics, Inc.
- 4D Molecular Therapeutics
- Wize Pharma Inc.
- Retina Implant AG
- Hoffmann-La Roche Ltd
- Kiora Pharmaceuticals
- Astellas Pharma Inc.
- Pixium Vision
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of choroideremia treatment is assessed at USD 10.21 billion.
The global choroideremia treatment market size was valued at over USD 9.79 billion in 2025 and is expected to expand at a CAGR of around 4.8%, surpassing USD 15.65 billion revenue by 2035.
North America is projected to hold the largest revenue share of 35% by 2035, impelled by its status as a hub of healthcare innovation and technology.
Key players in the market include A&T Well and Pump, A Plus Well Service Inc., Acona AS, AGR Holdco Ltd., BiSN Oil Tools Ltd., Calfrac Well Services Ltd., Coretrax Ltd., Dan Wood Co., Expro Group Holdings NV, Halliburton Co., Weatherford International, Japan Oil Development Co., Ltd., Japan Petroleum Exploration Co., Ltd., Air Liquide Japan G.K., Inpex Corporation.
